Cargando…
Mutation testing in melanoma families: INK4A, CDK4 and INK4D
The INK4A gene which codes for the cyclin-dependent kinase (CDK) inhibitor INK4A or p16 underlies susceptibility to melanoma in some families. Germline mutations in the gene that codes for the target protein of p16, CDK4, underlie susceptibility in very rare families. We report mutation screening of...
Autores principales: | Newton Bishop, J A, Harland, M, Bennett, D C, Bataille, V, Goldstein, A M, Tucker, M A, Ponder, B A J, Cuzick, J, Selby, P, Bishop, D T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363010/ https://www.ncbi.nlm.nih.gov/pubmed/10390011 http://dx.doi.org/10.1038/sj.bjc.6690354 |
Ejemplares similares
-
CDK6 Degradation Is Counteracted by p16(INK4A) and p18(INK4C) in AML
por: Schmalzbauer, Belinda S., et al.
Publicado: (2022) -
Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16(INK4A), P14(ARF) or cdk4 genes
por: Soufir, N, et al.
Publicado: (2000) -
P1412: UNCOUPLING INK4 PROTEINS FROM CDK4/CDK6 IN HEMATOPOIETIC STEM CELLS
por: Schirripa, A., et al.
Publicado: (2022) -
p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours
por: Le Frère-Belda, M A, et al.
Publicado: (2001) -
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
por: Li, Qing, et al.
Publicado: (2022)